BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).
Looking for a particular BioCytics Inc employee's phone or email?
The BioCytics Inc annual revenue was $8 million in 2026.
Jim Powderly is the Co-Founder and Strategic Development of BioCytics Inc.
13 people are employed at BioCytics Inc.
BioCytics Inc is based in Huntersville, North Carolina.
The NAICS codes for BioCytics Inc are [6215, 621, 62, 62151].
The SIC codes for BioCytics Inc are [80, 807].